Reuters With the coronavirus still widespread, it’s time to start thinking seriously about flu, which typically spreads in fall and winter. A major flu outbreak would not only overwhelm hospitals this fall and winter, but also likely overwhelm a person who can contract both at the same time. Doctors do …
Read More »
Despite the urgency of beating COVID-19, health officials may delay the development of an effective vaccine. Authorities in the U.S. and elsewhere have yet to authorize an ethical charge investigation procedure called “trials with human challenge.” Challenge tests deliberately involve volunteers with the disease – which explains the official retention …
Read More »
(Photo by Joe Raedle / Getty Images) Getty Images Text size Here’s what you need to know about the impact of Covid-19 to navigate the markets today. • President Donald Trump said Friday that McKesson would work with the U.S. government to spread a coronavirus vaccine if one is approved. …
Read More »
The UK government said on Friday it had signed deals for a further 90 million doses of coronavirus vaccines as the country raced to secure supplies of experimental shots to combat the pandemic. Under the new agreements in principle, the American medicine developer Novavax NVAX, + 7.12% will supply 60 …
Read More »
Text size Andrey Rudakov / Bloomberg Novavax said it has a deal with SK Bioscience to produce the antigen component of its Covid-19 vaccine candidate during the pandemic period. The stock jumped more than 9% Thursday morning. Novavax (ticker: NVAX) said its development and supply agreement with the South Korean …
Read More »